Rhinomed Ltd (RNO.AX) Key Developments | Reuters.com
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rhinomed Ltd's Turbine granted US FDA registration

Wednesday, 16 Jul 2014 08:00pm EDT 

Rhinomed Ltd:Says that it has granted registeration with US FDA as a medical device.The Turbine is an internal nasal dilator that increases airflow by an average of 38 pct. and can assist athletes as a valuable to solution to dyspnea (breathlessness) during aerobic exercise. 

Company Quote

-0.0010 -5.00%
30 Jun 2016